OBERWEIS ASSET MANAGEMENT INC/ recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
3333 Warrenville Road Lisle, IL 60532
As of the latest 13F report, the guru’s equity portfolio contained 172 stocks valued at a total of $427.00Mil. The top holdings were CSTM(13.06%), NVMI(10.33%), and DAVA(6.98%).
According to GuruFocus data, these were OBERWEIS ASSET MANAGEMENT INC/’s top five trades of the quarter.
Aehr Test Systems
During the quarter, OBERWEIS ASSET MANAGEMENT INC/ bought 333,039 shares of NAS:AEHR for a total holding of 508,339. The trade had a 1.1% impact on the equity portfolio. During the quarter, the stock traded for an average price of $13.46.
On 11/15/2022, Aehr Test Systems traded for a price of $25.65 per share and a market cap of $705.26Mil. The stock has returned 2.19% over the past year.
GuruFocus gives the company a financial strength rating of 10 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, Aehr Test Systems has a price-earnings ratio of 77.73, a price-book ratio of 13.64, a EV-to-Ebitda ratio of 67.37 and a price-sales ratio of 13.15.
The price-to-GF Value ratio is 2.90, earning the stock a GF Value rank of 1.
Sierra Wireless Inc
The guru sold out of their 143,700-share investment in NAS:SWIR. Previously, the stock had a 0.85% weight in the equity portfolio. Shares traded for an average price of $28.74 during the quarter.
On 11/15/2022, Sierra Wireless Inc traded for a price of $28.83 per share and a market cap of $1.13Bil. The stock has returned 55.17% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, Sierra Wireless Inc has a price-book ratio of 4.09, a EV-to-Ebitda ratio of 215.42 and a price-sales ratio of 1.69.
The price-to-GF Value ratio is 1.42, earning the stock a GF Value rank of 1.
Axcelis Technologies Inc
During the quarter, OBERWEIS ASSET MANAGEMENT INC/ bought 44,999 shares of NAS:ACLS for a total holding of 253,219. The trade had a 0.64% impact on the equity portfolio. During the quarter, the stock traded for an average price of $64.6.
On 11/15/2022, Axcelis Technologies Inc traded for a price of $78.1 per share and a market cap of $2.57Bil. The stock has returned 26.35% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Axcelis Technologies Inc has a price-earnings ratio of 16.27, a price-book ratio of 4.18, a price-earnings-to-growth (PEG) ratio of 0.55, a EV-to-Ebitda ratio of 11.01 and a price-sales ratio of 3.06.
The price-to-GF Value ratio is 1.16, earning the stock a GF Value rank of 3.
Endava PLC
OBERWEIS ASSET MANAGEMENT INC/ reduced their investment in NYSE:DAVA by 26,021 shares. The trade had a 0.58% impact on the equity portfolio. During the quarter, the stock traded for an average price of $94.98.
On 11/15/2022, Endava PLC traded for a price of $80.45 per share and a market cap of $4.57Bil. The stock has returned -51.65% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Endava PLC has a price-earnings ratio of 42.77, a price-book ratio of 8.57, a price-earnings-to-growth (PEG) ratio of 1.28, a EV-to-Ebitda ratio of 28.35 and a price-sales ratio of 5.45.
The price-to-GF Value ratio is 0.62, earning the stock a GF Value rank of 8.
Amphastar Pharmaceuticals Inc
During the quarter, OBERWEIS ASSET MANAGEMENT INC/ bought 83,600 shares of NAS:AMPH for a total holding of 101,500. The trade had a 0.55% impact on the equity portfolio. During the quarter, the stock traded for an average price of $32.65.
On 11/15/2022, Amphastar Pharmaceuticals Inc traded for a price of $28.37 per share and a market cap of $1.37Bil. The stock has returned 34.14% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, Amphastar Pharmaceuticals Inc has a price-earnings ratio of 19.04, a price-book ratio of 2.73, a price-earnings-to-growth (PEG) ratio of 0.56, a EV-to-Ebitda ratio of 9.76 and a price-sales ratio of 3.01.
The price-to-GF Value ratio is 1.06, earning the stock a GF Value rank of 5.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
